CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
The Maternal Embryonic Leucine Zipper Kinase (MELK) has been reported to be a genetic dependency in several cancer types. MELK RNAi and small-molecule inhibitors of MELK block the proliferation of various cancer cell lines, and MELK knockdown has been described as particularly effective against the...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/24179 |